XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Common Stock Held in Treasury
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021     95,746,975   107,820      
Beginning balance at Dec. 31, 2021 $ 709,624 $ (198) $ 68 $ 916,578 $ (897) $ (206,218) $ (198) $ 93
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1,112          
Common stock issued for exercise of employee stock options (in shares)     8,486          
Common stock issued for exercise of employee stock options 80     80        
Issuance of restricted shares, net of forfeitures and vesting (in shares)     533,095          
Issuance of restricted shares, net of forfeitures and vestings 0   $ 5 (5)        
Stock-based compensation 5,108     5,108        
Net income 6,236         6,236    
Unrealized loss on hedged transactions, net of tax 0              
Foreign currency translation adjustment, net of tax 275     (8)       283
Foreign currency translation adjustment, net of tax 283              
Ending Balance (in shares) at Mar. 31, 2022     96,289,668   107,820      
Ending Balance at Mar. 31, 2022 721,125   $ 73 921,753 $ (897) (200,180)   376
Beginning balance (in shares) at Dec. 31, 2022     96,717,883   1,047,237      
Beginning balance at Dec. 31, 2022 736,646   $ 76 942,789 $ (14,859) (186,448)   (4,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     4,567          
Issuance of restricted shares, net of forfeitures and vesting (in shares)     1,894,310          
Issuance of restricted shares, net of forfeitures and vestings $ 0   $ 19 (19)        
Repurchases of common stock (in shares) 493,926   493,926   493,926      
Repurchases of common stock $ (7,712)       $ (7,712)      
Shares withheld to cover restricted share vestings tax (in shares)     37,128   37,128      
Shares withheld to cover restricted share vestings tax (487)       $ (487)      
Stock-based compensation 8,043     8,043        
Net income 591         591    
Unrealized loss on hedged transactions, net of tax (5,159)             (5,159)
Foreign currency translation adjustment, net of tax 682             682
Ending Balance (in shares) at Mar. 31, 2023     98,085,706   1,578,291      
Ending Balance at Mar. 31, 2023 $ 732,604   $ 95 $ 950,813 $ (23,058) $ (185,857)   $ (9,389)